Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

npj Breast Cancer (3)
Nature Medicine (1)
Scientific Reports (1)
npj Precision Oncology (1)
Communications Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (6)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cancer
Diseases
Health care
Medical research
Oncology
Systems biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–7 of 7 results

Advanced filters: Author: Ornella Garrone Clear advanced filters

Predicting the response to immunotherapy from gene expression data in HER2-negative breast cancer

La Porta et al. present ARIADNE, an algorithm to analyze gene expression data in HER2-breast cancer patients. The predictive ability of response to immunotherapy is improved when complemented by a cytokine score.

Caterina A. M. La Porta
Ornella Garrone
Stefano Zapperi
ResearchOpen Access03 Oct 2025
Communications Medicine

Volume: 5, P: 1-8
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

A combination of real-world evidence and a reanalysis of phase 3 clinical trial data unveils KRAS codon G12 mutations as a biomarker of resistance to trifluridine/tipiracil in metastatic colorectal cancer.

Joris van de Haar
Xuhui Ma
Nicola Valeri
ResearchOpen Access02 Mar 2023
Nature Medicine

Volume: 29, P: 605-614
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan

Alessandra Fabi
Alessandro Rossi
Andrea Botticelli
ResearchOpen Access22 Jan 2025
npj Precision Oncology

Volume: 9, P: 1-8
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study

Simone Scagnoli
Simona Pisegna
Andrea Botticelli
ResearchOpen Access17 Jul 2024
npj Breast Cancer

Volume: 10, P: 1-10
Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study

Simone Scagnoli
Simona Pisegna
Andrea Botticelli
Amendments and CorrectionsOpen Access02 Aug 2024
npj Breast Cancer

Volume: 10, P: 1
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer

Fabio Puglisi
Lorenzo Gerratana
Lucia Del Mastro
ResearchOpen Access28 Jun 2021
npj Breast Cancer

Volume: 7, P: 1-9
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

Laura Pizzuti
Maddalena Barba
Patrizia Vici
ResearchOpen Access02 Jul 2021
Scientific Reports

Volume: 11, P: 1-10